Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive May 1, 2012	Country Report: South Africa In just the past few years, South Africa has hit several key economic benchmarks demonstrating the country's upward trajectory.
Pharmaceutical Executive December 1, 2011	UK Report: Keep Calm and Carry On ... Differently Even as the global economic roller coaster affects one of the country's dearest public institutions, the National Health Service, there is still reason for optimism in these times of austerity.
Pharmaceutical Executive June 1, 2011	Are You Ready for the New China? The ability to act as a good corporate citizen and assert a useful role in national industrial policy on health is going to be essential to success in the new China.
Chemistry World May 23, 2012 Andy Extance	Drug watchdogs mark out global territory The US Food and Drug Administration has published plans to ensure that American citizens continue to enjoy access to safe drugs, even as the regulatory pressures of globalization grow.
Pharmaceutical Executive October 1, 2006 Ray Hill	China: Big Rewards. Bigger Risks? The world's fastest growing pharmaceutical market may one day be the largest. Breaking in could be industry's greatest challenge.
Pharmaceutical Executive August 1, 2011 Ben Comer	Is the 'Emerging Market' a Dated Concept? When it comes to the emerging markets, executing a few key elements of success are more important than ever.
BusinessWeek November 8, 2004 Jason Bush	Will The Boom Last In Ukraine? Investors are praying that Ukraine's tumultuous election won't stifle its superhot economy.
Pharmaceutical Executive October 1, 2011	Pharma Futures: The Next 30 Years Success for the next 30 years in the pharmaceutical industry depends significantly on navigating the myths and mental traps of emerging market strategy.
Pharmaceutical Executive February 1, 2011 Jon Zifferblat	China: Business as UNusual If there is one market that requires a click on the 'refresh' button, it's China. General Biologic provides a snapshot of what's ahead for Big Pharma in the country
Pharmaceutical Executive September 1, 2012 Stan Bernard	The Payer C Change: From Customers to Competitors "Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets." Understanding why and how this payer shift to dominance occurred is critical for pharmaceutical professionals in adjusting their business model.
BusinessWeek December 13, 2004 Bush & Olearchyk	Putin's Biggest Blunder Is the Russian president losing his touch? Once admired for his steely efficiency, Putin suddenly doesn't seem to be able to get anything right.
Global Services December 1, 2008 Pratibha Verma	Outsourcing to Ukraine Despite domestic financial crisis, the country has seen $6.9 billion FDI in the first half of 2008, which is comparatively 170 percent more than the amount calculated in 2007, according to State Statistics Committee.
Finance & Development September 1, 2002 Mathieu & Shiells	The Commonwealth of Independent States' Troubled Energy Sectors The energy sector plays a large economic role in several of the countries of the former Soviet Union, given their vast reserves of oil and natural gas. But the sector is riddled with distortions and inefficiencies that hinder trade and keep the region from realizing its economic potential.
Chemistry World April 22, 2015 Eugene Gerden	Ukraine to slash science budget Rapid growth in defense spending has led Ukraine's president, Petr Poroshenko, to announce plans to cut science funding to the bone.
Pharmaceutical Executive June 1, 2014	Hopes High as EU Heads Into Leadership Change The principal drug industry associations in Europe launched a call in mid-May for "an integrated European industrial policy for the pharmaceuticals sector."
Chemistry World March 25, 2010 Rebecca Trager	Big pharma scores in US healthcare reform President Obama has signed the biggest US healthcare reform since the 1960s, and although it is largely seen as a victory for the pharmaceutical industry, some analysts are characterising it as a 'double-edged sword'.
BusinessWeek January 10, 2005 Roman Olearchyk	Ukraine: Why The Road West Will Be Rocky Many in Europe are reluctant to start the process that could bring Ukraine into NATO and the EU for fear of poisoning relations with Russian President Vladimir V. Putin.
Pharmaceutical Executive October 1, 2011 Daniel Vasella	Heart of Success: Patient-Centric R&D Drug discovery must remain a core competency of industry. The future success of individual companies will be tightly linked to success in R&D.
BusinessWeek September 3, 2007 Jason Bush	Ukraine: What Crisis? Despite political turmoil, economic growth is roaring in the Ukraine.
Pharmaceutical Executive June 1, 2013 Tom Reynolds	Finding Strategic Levers in the Supply Chain Customer-focused supply-chain capabilities are becoming a more important part of a company's competitive advantage.
Pharmaceutical Executive January 1, 2009 Stan Bernard	Pharma vs. Pharma The most successful pharmaceutical companies will be those that can transform as the industry itself transforms.
InternetNews August 31, 2005 Roy Mark	U.S. Lifts Ukraine's IP Sanctions The United States is lifting trade sanctions against the Ukraine in recognition of the country's latest efforts to protect intellectual property rights.
BusinessWeek September 3, 2007	Ukraine's Delicate Balance Ukrainian Finance Minister Mykola Azarov explains the disconnect between his country's unstable political situation and its impressive economic performance.
Pharmaceutical Executive August 1, 2005 Lena Chow	Docs of Shanghai They're short on status, pay, and respect, but China's young doctors hold keys to the world's fastest growing pharmaceutical market.
Finance & Development September 1, 2000 Oleh Havrylyshyn & John Odling-Smee	Political Economy of Stalled Reforms Powerful vested interests in some of the transition countries oppose further reform. But, even in this difficult climate, reform can and should continue.
AskMen.com June 7, 2012 Simon Kuper	Euro 2012 Host: Ukraine As Ukraine prepares to co-host Euro 2012, which begins Friday, the backdrop to soccer in this struggling country of 46 million people hasn't changed much. The game is still a great Ukrainian passion, and still a plaything of oligarchs and corrupt politicians.
Pharmaceutical Executive October 1, 2011	Regulation and Reputation: Still Two Solitudes The pharmaceutical and biopharmaceutical industries will only be able to continue providing patients with safe and effective medicines if the price is affordable. This will involve changes in attitudes by the industry, regulators, politicians, and the public.
Knowledge@Wharton August 27, 2003	Code Blue: Combating Rising Healthcare Costs Calls for Strong Medicine It's been said many times over that the U.S. healthcare industry is a sick patient in search of a cure. The metaphor is a grim reflection of how the country is coping with an aging population, rising costs and an inefficient healthcare delivery system.
Chemistry World April 5, 2012 Eugene Gerden	Ukrainian scientists battle chronic underfunding In recent years, due to the rising cost of Russian gas, the Ukrainian government has been forced to make drastic cuts to its federal spending, including science, which has sparked fierce criticism from the academic community.
Pharmaceutical Executive September 1, 2005 Wolfgang Klietmann	Thought Leader: (Eco)systemic Change The author discusses how various players within the healthcare system interact.
Pharmaceutical Executive July 1, 2012 Al Topin	Marketing: Why the Conversation Has Changed -- Forever At its core, pharma marketing is about conversations. Dynamic, persuasive conversations between companies and healthcare stakeholders. But one time it was simple; now it's not.
Pharmaceutical Executive March 1, 2013	China and the Emerging Markets Challenge: Why Big Pharma Must Embrace a New Strategy With health reform already tagged as a key domestic priority, their policies will pose new opportunities and challenges for Big Pharma companies active in China.
Pharmaceutical Executive May 1, 2007 Humphrey Taylor	Commentary: The Sky is Falling! Healthcare systems in the developed world are in crisis. A permanent one. Patients and their physicians will always want more treatments than governments or employers are willing to pay for.
Pharmaceutical Executive May 1, 2005 Sarah Houlton	Global Report: Iron Fist The United Kingdom is hardening its stance on pharma industry issues.
Pharmaceutical Executive October 1, 2005 Philip A. George	Backpage: Under Surveillance Doctors and consumers don't doubt that pharma benefits society. But in the eyes of the public, industry efforts to monitor postmarket safety come up short.
Finance & Development March 2009	Deep Impact Four countries -- Ukraine, Singapore, Burkina Faso, and Ireland -- confront the harsh and disruptive effects of the global economic downturn.
BusinessWeek November 8, 2004 Jason Bush	Building The Muscle To Be A Tech Player Some of the biggest names in the global technology industry have started to wake up to Ukraine's potential.
Pharmaceutical Executive October 1, 2005	Public Relations: Communications Delivery Chain An interview with Nanccy Turett, president of Edelman Health on how, to regain consumers' trust, pharma must better communicate its mission, goals, and policies.
The Motley Fool November 30, 2010 Brian Orelli	A Witty Response to Pharma's R&D Dilemma According to GlaxoSmithKline CEO Andrew Witty, the pharmaceutical industry is a mess. That's the basic gist of his opinion piece in The Economist.
Pharmaceutical Executive November 1, 2008 Sarah Houlton	Cash Flow Woes in EU In Europe, the wildly different attitudes toward healthcare across the different member states make for a complex pharmaceutical marketplace.
BusinessWeek January 14, 2010 Gomez & Krasnolutska	Can Ukraine Say 'Nyet' to Political Squabbles? If presidential elections usher in stability in Kiev, the economy stands a chance of returning to growth
Financial Planning April 1, 2006 Donald Jay Korn	Rx for Investing Healthcare stocks may cure investors' ills over the long term, but the current prognosis is less clear. For clients in diversified funds, planners should decide whether additional healthcare exposure is justified, through individual stocks or specialized funds.
Wired March 2002 Jack Boulware	Pirates Of Kiev You want Top 40? How about nine albums on one disc - three bucks. Microsoft Office XP? Two dollars and change. Welcome to Ukraine, where rip, mix, and burn is a point of national pride...
Pharmaceutical Executive September 1, 2008 Herschman & Khorover	The New Code Effective January 1st, sales reps will have a new standard for dealing with doctors with a revised "Code on Interactions with Healthcare Professionals."
HBS Working Knowledge July 12, 2006 Roger Thompson	Competition the Cure for Healthcare Michael Porter is considered by many the world's foremost authority on competition and strategy. So when he discusses the need for fundamental reform in the way the United States delivers healthcare, people listen.
Commercial Investment Real Estate May/Jun 2013 Mauldin & Maddron	Medical Office Momentum The Affordable Care Act takes some risk out of healthcare property investment.
Pharmaceutical Executive August 1, 2006 Patrick Clinton	From the Editor: Take Your Seat There's a lot to accomplish in the pharmaceutical industry. But considering what the industry has done in 25 years, it's not impossible.
The Motley Fool January 5, 2009 David Lee Smith	Will Russia's Squabble Affect You? Yet again, Russia and Ukraine are at crossed swords in a gas-pricing dispute.
BusinessWeek December 6, 2004 Jason Bush	A Political Crisis Erupts In Ukraine Ukraine is in political turmoil after hundreds of thousands of demonstrators took to the streets of Kiev and other cities to protest the results of a hotly contested presidential election.
Pharmaceutical Executive March 1, 2012 B. Brett Heavner	Judging a Pill by its Cover Pharmaceutical trade dress is an effective marketing tool that helps boost product recognition for consumers. It's worth protecting.